gsk2190915
Small moleculeexperimental
Clinical trial activity
13 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
8
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2008 (NCT00748306)
Timeline
Indications
Studied for
Mechanism of action
- 5-lipoxygenase activating proteinINHIBITOR
ALOX5AP inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1- Mol. weight
- 637.85 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1922660 ↗
- ChEMBLCHEMBL1922673 ↗
Also known as
- 3-(3-tert-butylsulfanyl-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-(5-methylpyridin-2-ylmethoxy)-1h-indol-2-yl)-2,2-dimethylpropionic acid
- am 803
- am-803
- fiboflapon
- fiboflapon
- fiboflapon sodium
- fiboflapon sodium
- gsk2190915
- gsk2190915
- gsk2190915
- gsk2190915a
- gsk2190915a
- gsk2190915b
- gsk2190915b
- sodium salt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01471665 | Phase 2 | Jun 1, 2011 | GlaxoSmithKline |
| NCT01411111 | Phase 1 | Jan 1, 2011 | GlaxoSmithKline |
| NCT01248975 | Phase 2 | Dec 1, 2010 | GlaxoSmithKline |
| NCT01286844 | Phase 2 | Nov 1, 2010 | GlaxoSmithKline |
| NCT01318980 | Phase 1 | Sep 1, 2010 | GlaxoSmithKline |
| NCT01721135 | Phase 1 | Sep 1, 2010 | GlaxoSmithKline |
| NCT01156792 | Phase 2 | Sep 1, 2010 | GlaxoSmithKline |
| NCT01147744 | Phase 2 | Jun 1, 2010 | GlaxoSmithKline |
| NCT00955383 | Phase 1 | Aug 14, 2009 | GlaxoSmithKline |
| NCT02224521 | Phase 1 | Apr 20, 2009 | GlaxoSmithKline |
| NCT00812929 | Phase 2 | Dec 1, 2008 | GlaxoSmithKline |
| NCT00812773 | Phase 2 | Dec 1, 2008 | GlaxoSmithKline |
| NCT00748306 | Phase 2 | Dec 1, 2008 | GlaxoSmithKline |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 13 | 13 | 2 | 2008 |
1 organizations
Page 1 / 1